EP2083863
ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
3.10.2007EP published:
18.3.2015EP application number:
07867199.7
EPO information:
European Patent Register
Max expiry date:
2.10.2027
Title:
ANTIBODIES TO TGF-BETA FOR USE IN THE TREATMENT OF INFANTS AT RISK OF DEVELOPING BRONCHOPULMONARY DYSPLASIA
Timeline
Today
3.10.2007EP application
18.3.2015EP Publication
Owner
Name:
Genzyme CorporationAddress:
500 Kendall Street, 02142, Cambridge, MA, US
Name:
The General Hospital CorporationAddress:
Massachusetts General Hospital 55 Fruit Street, 02114, Boston, MA, US
Inventor
Name:
STREISAND, James B.Address:
Cambridge, MA, US
Name:
ROBERTS, Jesse D. Jr.Address:
Brighton, MA, US
Priority
Number:
827933 PDate:
3.10.2006Country:
US
Classification
Categories:
A61K 39/395, A61P 11/00, C07K 16/22, A61K 45/06